The newly established UC San Diego BEACON for Lp(a) Research is pleased to invite applications for its 2026 Pilot Project Grant Program. These one-year awards of $25,000 are intended to support early stage, innovative research focused on lipoprotein(a) [Lp(a)]. A total of two projects will be funded.
Researchers from UC San Diego School of Medicine found that testing for lipoprotein(a) — a genetic risk factor for heart disease — remains uncommon in the United States, despite modest increases over the past decade.
People with high blood pressure that is uncontrolled or poorly treated with most medications may benefit from a new drug that is showing promise in clinical trial results, according to a study ...
Metabolic syndrome is linked to greater risk of developing young-onset dementia, according to a new study. But there are preventive changes you can make today.
January 29, 2025 – Roche announced today that the Tina-quant Lipoprotein (a) Gen.2 Molarity assay has received 510(k) clearance from the United States Food and Drug Administration (FDA). This will be the first 510(k) cleared test of its kind available in the U.S. measuring lipoprotein (a), or Lp(a), in nanomoles per liter (nmol/L). The National Lipid Association (NLA) recommends all adults ...
